Adenosquamous cell lung cancer stage II is a rare and complex form of lung cancer that combines two different cell types within the same tumor, making it particularly challenging to diagnose and treat. Though uncommon, this cancer type has distinct characteristics that set it apart from more typical lung cancers, and understanding it can help patients and their families navigate treatment decisions more effectively.

What Is Adenosquamous Cell Lung Cancer Stage II?

Adenosquamous cell lung cancer is an uncommon subtype of non-small cell lung cancer (NSCLC), which refers to the broader category of lung cancers that grow more slowly than small cell types. This particular cancer is unique because it contains components of both adenocarcinoma (cancer that begins in cells that produce mucus and other substances) and squamous cell carcinoma (cancer that forms in the thin, flat cells lining the airways). According to medical definitions, each of these two cell types must make up at least 10% of the tumor for it to be classified as adenosquamous carcinoma.^[1]

When doctors identify this cancer as stage II, they are describing how far the disease has spread in the body. Stage II means the cancer is larger than in stage I or has begun to reach nearby lymph nodes (small structures that filter harmful substances and are part of the immune system), but it has not traveled to distant organs.^[2] This staging helps guide treatment decisions and gives patients an understanding of their prognosis.

The staging system used for this cancer is quite specific. Stage II is divided into two substages: IIA and IIB. In Stage IIA, the tumor might be between certain sizes but hasn’t reached lymph nodes outside the lung, or it could be smaller but has spread to lymph nodes within the lung. Stage IIB typically means the tumor has grown larger or has spread to lymph nodes near the lung but not to distant parts of the body.^[2] The detailed staging system helps doctors determine the best course of action for each individual patient.

Who Gets Adenosquamous Cell Lung Cancer?

The typical patient diagnosed with adenosquamous carcinoma of the lung shares many characteristics with people who develop other types of lung cancer. The average age at diagnosis is around 70 years, though it can occur at different ages. This cancer affects more men than women, and the majority of patients are either current or former smokers.^[4] This pattern suggests that tobacco exposure plays a significant role in the development of this disease.

When looking at broader lung cancer patterns, we know that lung cancer ranks as the third most common cancer in the United States.^[3] Within this larger group, adenosquamous carcinoma represents a small subset. The rarity of this particular subtype means that comprehensive data about its specific epidemiology is limited, but research continues to help doctors better understand who is most at risk.

What Causes This Type of Cancer?

Like other lung cancers, adenosquamous cell lung cancer develops when normal cells in the lungs undergo changes, called mutations, in their genetic material. These mutations cause cells to divide and multiply uncontrollably instead of following their normal, orderly pattern of growth and death. Over time, these damaged cells accumulate and form a mass or tumor that can interfere with lung function and spread to other parts of the body.^[3]

The primary cause of adenosquamous lung cancer, like most lung cancers, is cigarette smoking. Tobacco smoke contains thousands of harmful chemicals that damage the cells lining the airways. With repeated exposure over many years, these cells can accumulate enough genetic damage to become cancerous. Even people who have quit smoking years ago remain at elevated risk compared to those who never smoked, though the risk does decrease over time after quitting.

What makes adenosquamous carcinoma particularly interesting to researchers is its mixed nature. Scientists are still investigating exactly how and why a single tumor develops two distinct cell types. Some theories suggest that the cancer originates from a single stem cell that differentiates into two different cell types during tumor growth. Others propose it might start as one type of cancer that undergoes changes to produce the second cell type.^[4] Regardless of its origin, the dual nature of this cancer means it carries genetic characteristics from both adenocarcinoma and squamous cell carcinoma.

Risk Factors

Smoking stands as the single most important risk factor for adenosquamous lung cancer. The risk increases with the number of cigarettes smoked per day and the total number of years a person has smoked. Former smokers face lower risk than current smokers, but their risk remains higher than people who never smoked. Exposure to secondhand smoke also increases risk, though to a lesser degree than direct smoking.

Environmental and occupational exposures can contribute to lung cancer risk as well. People who work with certain substances such as asbestos, certain metals, or industrial chemicals may have increased risk. Exposure to high levels of air pollution over many years has also been linked to lung cancer development. Additionally, exposure to radon gas, a naturally occurring radioactive gas that can accumulate in homes, has been identified as a lung cancer risk factor.

Family history may play a role, though this is less clearly defined for adenosquamous carcinoma specifically. People with close relatives who had lung cancer may face slightly elevated risk, possibly due to shared genetic factors that make cells more susceptible to damage, or due to shared environmental exposures. Previous radiation therapy to the chest area, such as treatment for another cancer, can also increase the risk of developing lung cancer later in life.

Symptoms of Stage II Adenosquamous Lung Cancer

In stage II, symptoms may still be relatively mild or even absent in some cases, which is one reason why lung cancer sometimes goes undetected until it has progressed. When symptoms do appear, they often resemble those of more common respiratory conditions like bronchitis or pneumonia, which can lead to delays in diagnosis.

The most common symptom is a persistent cough that doesn’t go away or gets worse over time. This cough might produce mucus, and sometimes the mucus contains blood, which should always prompt immediate medical evaluation. Patients may experience shortness of breath, even with minimal physical activity, as the tumor interferes with normal lung function. Chest pain that worsens with deep breathing, coughing, or laughing can also occur.

Other symptoms might include repeated respiratory infections such as bronchitis or pneumonia, as the tumor can block airways and create an environment where bacteria can thrive. Some people experience hoarseness or voice changes if the tumor affects nerves that control the vocal cords. Unexplained weight loss and loss of appetite are also common, along with fatigue that doesn’t improve with rest. Some patients report feeling generally unwell without being able to pinpoint a specific symptom.

How Is It Diagnosed?

Diagnosing adenosquamous carcinoma of the lung presents unique challenges because of its mixed cell composition. The diagnosis process typically begins when a patient experiences symptoms or when an abnormality is spotted on a chest X-ray or CT scan done for another reason. However, identifying this specific cancer type requires obtaining actual tissue samples.

One of the most significant challenges with adenosquamous carcinoma is that it is frequently misdiagnosed initially. Studies have shown that this cancer is misdiagnosed as either pure adenocarcinoma or pure squamous cell carcinoma in at least half of biopsy cases before surgery.^[4] This happens because small biopsy samples (small pieces of tissue removed for examination) may only capture one component of the tumor, missing the mixed nature entirely.

The most reliable way to diagnose adenosquamous carcinoma is through examination of surgically removed tissue. When surgeons remove part or all of the affected lung, pathologists can examine the entire tumor and identify both the adenocarcinoma and squamous cell carcinoma components.^[1] This is why the definitive diagnosis often comes after surgery rather than before.

Before surgery, doctors use various imaging tests to understand the size and location of the tumor and whether it has spread. Computed tomography (CT) scans provide detailed cross-sectional images of the chest and can show the tumor’s size, shape, and relationship to nearby structures. Positron emission tomography (PET) scans can help identify whether cancer has spread to lymph nodes or other parts of the body by detecting areas of high metabolic activity characteristic of cancer cells.

Doctors may also perform bronchoscopy, a procedure where a thin, flexible tube with a camera is inserted through the mouth or nose into the airways. This allows direct visualization of the tumor and collection of tissue samples. However, as mentioned, these samples may not always reveal the true mixed nature of the cancer.

Prevention

The most effective way to prevent adenosquamous lung cancer is to avoid tobacco smoke entirely. For people who have never smoked, not starting is the best protection. For current smokers, quitting at any age significantly reduces the risk of developing lung cancer, and the risk continues to decrease the longer a person remains smoke-free. Many resources exist to help people quit smoking, including medications, counseling, support groups, and smoking cessation programs.

Reducing exposure to other known risk factors also helps with prevention. People should test their homes for radon and take steps to reduce levels if they are elevated. Those who work in industries with exposure to known carcinogens should follow all safety protocols, use protective equipment properly, and participate in workplace health monitoring programs when available.

For people at high risk due to their smoking history, screening with low-dose CT scans may be recommended. Screening can detect lung cancer at earlier, more treatable stages before symptoms appear. Current guidelines recommend annual lung cancer screening for adults aged 50 to 80 who have a significant smoking history and currently smoke or have quit within the past 15 years.^[3] Anyone considering screening should discuss the benefits and potential risks with their healthcare provider.

Maintaining overall health through a balanced diet rich in fruits and vegetables, regular physical activity, and avoiding excessive alcohol consumption may also contribute to cancer prevention, though these measures are not as directly protective against lung cancer as avoiding tobacco smoke.

How the Disease Affects the Body

Understanding what happens inside the body when adenosquamous lung cancer develops can help patients grasp why they experience certain symptoms and why specific treatments are recommended. In a healthy lung, air travels through branching airways called bronchi and bronchioles, eventually reaching tiny air sacs called alveoli where oxygen enters the bloodstream and carbon dioxide is removed.^[3]

When adenosquamous carcinoma forms, the tumor mass physically occupies space in the lung tissue. As it grows, it can partially or completely block airways, preventing air from reaching parts of the lung. This blockage explains why patients often experience shortness of breath and reduced exercise tolerance. The blocked areas of lung tissue may collapse, a condition called atelectasis, or they may become infected repeatedly because mucus cannot drain properly.

The cancer cells themselves don’t follow normal growth patterns. While healthy lung cells have orderly cycles of growth, division, and death, cancer cells ignore the signals that usually control these processes. They divide rapidly and don’t die when they should, forming a growing mass. This uncontrolled growth requires significant energy and resources, which the tumor diverts from normal body functions. This partly explains the fatigue and weight loss many patients experience.

In stage II disease, the cancer may have begun spreading to nearby lymph nodes. Lymph nodes normally filter lymph fluid and trap harmful substances like bacteria or cancer cells. When cancer cells reach lymph nodes, they can continue growing there, causing the nodes to enlarge. From the lymph nodes, cancer cells can potentially spread through the lymphatic system or bloodstream to other organs, though by definition, stage II cancer has not yet spread to distant sites.

The mixed nature of adenosquamous carcinoma means the tumor contains two different cell populations with potentially different growth patterns and characteristics. The adenocarcinoma component typically grows in a gland-like pattern and may produce mucus, while the squamous component forms in flat, scale-like cells. This heterogeneity makes the tumor more complex and is one reason it tends to behave more aggressively than pure adenocarcinomas or squamous cell carcinomas.

Research suggests that adenosquamous carcinoma has higher rates of lymph node invasion (spread to lymph nodes) compared to other NSCLC types, and it tends to spread to distant sites more readily.^[4] This aggressive behavior reflects the underlying biology of the tumor, where genetic mutations in the cancer cells give them advantages in growth, survival, and the ability to invade surrounding tissues.

At the molecular level, adenosquamous carcinomas may carry various genetic mutations. Studies have found that approximately 30% of these tumors have mutations in the EGFR gene (epidermal growth factor receptor), which is involved in cell growth signaling. Other common mutations include changes in the p53 gene, which normally helps control cell division and death, and rearrangements in the ALK gene, found in about 5% of cases.^[4] These genetic characteristics can influence treatment options and prognosis.